Ryan Richardson
Net worth: - $ as of 2026-06-29
Net worth: - $ as of 2026-06-29
Ryan Richardson is currently Director at Autolus Therapeutics Plc since 2025.
Formerly, Mr. Richardson was Chief Strategy Officer at BioNTech SE from 2020 to 2025 and worked at JP Morgan Services LLC as Executive Director-Healthcare Investment Banking.
Mr. Richardson completed undergraduate studies at the University of Kansas, graduate studies at the London School of Economics & Political Science, and earned an MBA from The University of Chicago Booth School of Business.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-28 | 0 ( -.--% ) | - $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Director/Board Member | 2025-11-30 |
| Companies | Position | End |
|---|---|---|
| BIONTECH SE | Corporate Officer/Principal | 2025-09-29 |
JP Morgan Services LLC
JP Morgan Services LLC Investment ManagersFinance Provides investment advice services | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
University of Kansas
University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
London School of Economics & Political Science
London School of Economics & Political Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioNTech SE
BioNTech SE BiotechnologyHealth Technology Develops immunotherapies and mRNA-based vaccines to treat cancer & infectious diseases | Health Technology |
The University of Chicago Booth School of Business
The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
JP Morgan Services LLC
JP Morgan Services LLC Investment ManagersFinance Provides investment advice services | Finance |
Autolus Therapeutics Plc
Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
Select your edition
All financial news and data tailored to specific country editions